COSCIENS Biopharma Inc. Noncurrent Provisions For Employee Benefits
COSCIENS Biopharma Inc. (CSCIF) had Noncurrent Provisions For Employee Benefits of $10.98 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:NoncurrentProvisionsForEmployeeBenefits · last filed 2026-03-25
- 2025-12-31: Noncurrent Provisions For Employee Benefits $10.98M.
- 2025-09-30: Noncurrent Provisions For Employee Benefits $11.81M.
- 2025-06-30: Noncurrent Provisions For Employee Benefits $11.81M.
- 2025-03-31: Noncurrent Provisions For Employee Benefits $11.04M.
| Period end | Noncurrent Provisions For Employee Benefits |
|---|---|
| 2025-12-31 | $10.98M 20-F · filed 2026-03-25 |
| 2025-09-30 | $11.81M 6-K · filed 2025-11-12 |
| 2025-06-30 | $11.81M 6-K · filed 2025-08-14 |
| 2025-03-31 | $11.04M 6-K · filed 2025-05-13 |
| 2024-12-31 | $11.73M 20-F · filed 2026-03-25 |
| 2024-09-30 | $12.45M 6-K · filed 2024-11-12 |
| 2024-06-30 | $11.03M 6-K · filed 2024-08-13 |
| 2024-03-31 | $12.02M 6-K · filed 2024-05-16 |
| 2023-12-31 | $12.62M 20-F/A · filed 2024-07-17 |
| 2023-09-30 | $10.11M 6-K · filed 2023-11-09 |
| 2023-06-30 | $11.38M 6-K · filed 2023-08-09 |
| 2023-03-31 | $11.50M 6-K · filed 2023-05-09 |
| 2022-12-31 | $11.16M 20-F/A · filed 2024-07-17 |
| 2022-09-30 | $9.46M 6-K · filed 2022-11-03 |
| 2022-06-30 | $8.19M 6-K/A · filed 2022-08-04 |
| 2022-03-31 | $14.39M 6-K · filed 2022-05-11 |
| 2021-12-31 | $17.48M 20-F/A · filed 2024-02-15 |
| 2021-09-30 | $14.21M 6-K · filed 2021-11-04 |
| 2021-06-30 | $14.87M 6-K · filed 2021-08-05 |
| 2021-03-31 | $13.81M 6-K · filed 2021-05-05 |
| 2020-12-31 | $15.44M 20-F · filed 2022-03-29 |
| 2020-09-30 | $14.85M 6-K · filed 2020-11-05 |
| 2020-06-30 | $13.68M 6-K · filed 2020-08-06 |
| 2020-03-31 | $12.06M 6-K/A · filed 2020-05-11 |
| 2019-12-31 | $13.79M 40-F/A · filed 2021-03-29 |
| 2019-09-30 | $14.48M 6-K · filed 2019-11-07 |
| 2019-06-30 | $14.56M 6-K · filed 2019-08-13 |
| 2018-12-31 | $13.21M 20-F · filed 2020-03-31 |
| 2017-12-31 | $14.23M 20-F · filed 2019-04-01 |
| 2016-12-31 | $13.41M 20-F · filed 2018-03-28 |